SCHEMBL5492983

SCHEMBL5492983

O=CC(=O)N1CCc2ccccc21

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.64
ALDH1A1 P00352 9/20 0.63
LMNA P02545 2/20 0.63
TSHR P16473 5/20 0.62
HPGD P15428 1/20 0.60
SMN1; SMN2 Q16637 5/20 0.58
MAPT P10636 4/20 0.58
NPC1 O15118 4/20 0.58
RAB9A P51151 4/20 0.58
PKM P14618 3/20 0.58
NFKB1 P19838 3/20 0.58
NFKB2 Q00653 3/20 0.58
RELA Q04206 3/20 0.58
HTT P42858 2/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
SIGMAR1 Q99720 1/20 0.58
POLB P06746 1/20 0.57
CHRNA7 P36544 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10899996 0.84 NOTUM (0.62) NOTUMALDH1A1LMNATSHRHPGD
SCHEMBL29611497 0.84 NOTUM (0.62) NOTUMALDH1A1LMNATSHRHPGD
SCHEMBL789554 0.83 ALDH1A1 (0.71) NOTUMALDH1A1LMNATSHRHPGD
SCHEMBL29449730 0.83 ALDH1A1 (0.71) NOTUMALDH1A1LMNATSHRHPGD
Hydrochloric Acid SCHEMBL10741975 0.81 ALDH1A1 (0.69) NOTUMALDH1A1LMNATSHRHPGD
SCHEMBL4780895 0.81 KMT2A (0.83) NOTUMALDH1A1LMNATSHRHPGD
SCHEMBL4016843 0.81 ALDH1A1 (0.66) NOTUMALDH1A1LMNATSHRHPGD
SCHEMBL4016837 0.81 ALDH1A1 (0.66) NOTUMALDH1A1LMNATSHRHPGD
SCHEMBL5492978 0.81 SMN1; SMN2 (0.79) NOTUMALDH1A1LMNATSHRHPGD
SCHEMBL29804966 0.81 NOTUM (0.72) NOTUMALDH1A1LMNATSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458734-A4 DERIVATIVES OF ISOINDIGO, INDIGO AND INDIRUBIN AND USE IN TREATING CANCER NATROGEN THERAPEUTICS INC (US) 2007-12-19 EP claimed
EP-1458734-A1 DERIVATIVES OF ISOINDIGO, INDIGO AND INDIRUBIN AND USE IN TREATING CANCER Natrogen Therapeutics, Inc. (US) 2004-09-22 EP claimed
WO-2003051900-A1 DERIVATIVES OF ISOINDIGO, INDIGO AND INDIRUBIN AND USE IN TREATING CANCER NATROGEN THERAPEUTICS, INC. (US) 2003-06-26 WO claimed